Anti-bacterial agents
Showing 1 - 25 of >10,000
Osteomyelitis-associated Pressure Ulcers by Surgical Flaps and
Not yet recruiting
- Disability or Chronic Disease Leading to Disablement
- +2 more
- Surgical flap and anti-bacterial agents
-
Garches, FranceDepartment of Physical Medicine and Rehabilitation, Raymond Poin
Feb 1, 2023
Cat Bite, Hand Injuries, Arm Injury Trial (drug, other, procedure)
Not yet recruiting
- Cat Bite
- +4 more
- Amoxicillin/clavulanate
- +4 more
- (no location specified)
Apr 26, 2023
Biliary Atresia, Cholangitis, Anti-Bacterial Agents Trial (Basic treatment: sulperazone + ursodeoxycholic acid + compound
Not yet recruiting
- Biliary Atresia
- +2 more
- Basic treatment: sulperazone + ursodeoxycholic acid + compound glycyrrhizin + methylprednisolone + vitamin AD , D , E , K + imipenem or meropenem
- Prophylactic oral antibiotics: compound sulfamethoxazole tablet (SMZ/TMP) + cefaclor
- (no location specified)
Jun 28, 2023
Alcohol Drinking, Alcohol-Related Disorders, Disease Trial in Catonsville (Minocycline, Sugar pill)
Recruiting
- Alcohol Drinking
- +15 more
- Minocycline
- Sugar pill
-
Catonsville, MarylandMaryland Psychiatric Research Center (MPRC) Treatment Research P
Nov 29, 2022
Fractures, Open, Wounds and Injuries--Infections, Anti-Bacterial Agents Trial in Aurora, Denver (Vancomycin, Tobramycin)
Active, not recruiting
- Fractures, Open
- +5 more
-
Aurora, Colorado
- +1 more
Jan 23, 2023
Plastic Surgery, Mammaplasty, Anti-bacterial Agents Trial in Pouso Alegre (Cephazolin, Sterile saline)
Recruiting
- Plastic Surgery
- +4 more
- Cephazolin
- Sterile saline
-
Pouso Alegre, MG, BrazilHospital das Clinicas Samuel Libânio, Universidade do Vale do Sa
Jul 25, 2022
Tumors Trial in San Jose del Cabo, Torreon (Anti-Bacterial Agents, Anti-Fungal Agents, Anti-Protozoal Agents)
Recruiting
- Neoplasms
- Anti-Bacterial Agents
- +2 more
-
San Jose del Cabo, Baja California Sur, Mexico
- +1 more
Mar 26, 2022
Microbiota, Anti-bacterial Agents Trial in Saint Louis (Levofloxacin, Azithromycin, Cefpodoxime)
Active, not recruiting
- Microbiota
- Anti-bacterial Agents
- Levofloxacin
- +2 more
-
Saint Louis, MissouriWashington University School of Medicine
Jan 26, 2022
Periprosthetic Joint Infection, Anti-Bacterial Agents Trial in Fuzhou (Antibiotics treatment)
Recruiting
- Periprosthetic Joint Infection
- Anti-Bacterial Agents
- Antibiotics treatment
-
Fuzhou, Fujian, ChinaThe First Affiliated Hospital of Fujian Medical University
Mar 9, 2022
Prevention & Control, Diarrhea Caused by Drug, Respiratory Infection Bacterial Trial in Belgrade, Novi Sad (drug product:
Completed
- Prevention & Control
- +3 more
- drug product: capsules are containing S. boulardii, administered twice daily (250 mg)
-
Belgrade, Serbia
- +1 more
Feb 19, 2022
Anti-bacterial Agents, Pharmacokinetics, General Surgery Trial in Seoul (target-controlled infusion (one of the administration
Recruiting
- Anti-bacterial Agents
- +2 more
- target-controlled infusion (one of the administration methods)
- Standard administration method
-
Seoul, Songpa-Gu,, Korea, Republic ofAsan Medical Center
Apr 11, 2022
Preterm Birth, Obstetric Labor, Premature, Obstetric Labor Complications Trial in Chicago, New Brunswick (Azithromycin 1 gram
Recruiting
- Preterm Birth
- +8 more
- Azithromycin 1 gram IV
- Cefazolin and indomethacin
-
Chicago, Illinois
- +1 more
Feb 28, 2022
Healthy Volunteers, Anti-Bacterial Agents, Methicillin-Resistant Staphylococcus Aureus Trial in Seoul (N-Rephasin® SAL200,
Completed
- Healthy Volunteers
- +2 more
- N-Rephasin® SAL200
- INT200-Placebo
-
Seoul, Korea, Republic ofSeoul National University Hospital
Oct 7, 2021
Staphylococcus Aureus Bacteremia, Anti-Bacterial Agents Trial in Seongnam-si, Seoul (N-Rephasin® SAL200, Placebo)
Terminated
- Staphylococcus Aureus Bacteremia
- Anti-Bacterial Agents
- N-Rephasin® SAL200
- Placebo
-
Seongnam-si, Gyeonggi-do, Korea, Republic of
- +1 more
Sep 12, 2021
Healthy Volunteers, Anti-Bacterial Agents, Methicillin-Resistant Staphylococcus Aureus Trial in Seoul (N-Rephasin® SAL200,
Completed
- Healthy Volunteers
- +3 more
- N-Rephasin® SAL200
- INT200-Placebo
-
Seoul, Korea, Republic ofSeoul National University Hospital
Oct 26, 2021
Anti-Bacterial Agents, Respiratory Tract Infections Trial in Indianapolis, Sioux Falls (Audit-and-feedback)
Completed
- Anti-Bacterial Agents
- Respiratory Tract Infections
- Audit-and-feedback
-
Indianapolis, Indiana
- +1 more
Apr 2, 2021
The Effects of Antibiotic Combinations on Stem Cells
Completed
- Stem Cells
- Anti-Bacterial Agents
- Differentiation Markers
-
Eskişehir, TurkeyEskişehir Osmangazi University
Jan 13, 2021
Infant, Newborn, Neonatal SEPSIS, Anti-bacterial Agents Trial in India (7-day course of antibiotics, 14-day course of
Recruiting
- Infant, Newborn
- +3 more
- 7-day course of antibiotics
- 14-day course of antibiotics
-
Rohtak, Haryana, India
- +5 more
Mar 9, 2021
Stroke, Medication Adherence Trial in Kumasi (Polycap)
Not yet recruiting
- Stroke
- Medication Adherence
-
Kumasi, GhanaKwame Nkrumah Institute of Science & Technology
Jul 19, 2023
Uncomplicated Plasmodium Falciparum Malaria Trial (INE963, KAE609, SoC (Coartem))
Not yet recruiting
- Uncomplicated Plasmodium Falciparum Malaria
- INE963
- +3 more
- (no location specified)
Feb 17, 2023
Relapsed/Refractory Non-Hodgkin Lymphoma Trial in Duarte, Amsterdam (BMS-986458, Rituximab)
Not yet recruiting
- Relapsed/Refractory Non-Hodgkin Lymphoma
-
Duarte, California
- +1 more
Oct 13, 2023
Solid Tumor Trial in Chuo-ku (ROSE12, Atezolizumab)
Recruiting
- Solid Tumor
-
Chuo-ku, Tokyo, JapanNational Cancer Center Hospital
Jun 14, 2023
Bacterial Metallophores in the Diagnosis of Acute Pyelonephritis
Recruiting
- Acute Pyelonephritis
- Complicated Urinary Tract Infection
-
Praha, CzechiaThomayer University Hospital
Jan 3, 2023
Therapeutic Drug Monitoring - Targeting IMproved Effectiveness
Not yet recruiting
- Pneumonia
- +2 more
- No intervention
- (no location specified)
Jul 25, 2023